Skip to main content

Table 1 Baseline characteristics of patients with severe haemophilia B in CHESS II

From: Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe

 

All patients

(n = 75)

SHL

(n = 42)

EHL

(n = 33)

Age, mean (SD)

36.2 (15.97)

33.7 (14.26)

39.3 (17.66)

Weight, kg, mean (SD)

77.3 (11.07)

74.0 (11.58)

79.9 (10.06)

Country, n (%)

   

 UK

22 (29)

15 (36)

7 (21)

 Italy

17 (23)

11 (26)

6 (18)

 Spain

15 (20)

9 (21)

6 (18)

 France

11 (15)

4 (10)

7 (21)

 Germany

10 (13)

3 (7)

7 (21)

Medical history, n (%)

   

 Anxiety

9 (12)

5 (12)

4 (12)

 Depression

5 (7)

4 (10)

1 (3)

 HIV

1 (1)

0

1 (3)

 Hepatitis B

4 (5)

3 (7)

1 (3)

 Hepatitis C

9 (12)

4 (10)

5 (15)

FIX prophylaxis treatment, n (%)

   

 EHL

33 (44)

33 (100)

 SHL

42 (56)

42 (100)

Primary FIX prophylaxis, n (%)

57 (76)

29 (69)

28 (85)

Secondary FIX prophylaxis, n (%)

18 (24)

13 (31)

5 (15)

  1. EHL, extended half-life; FIX, Factor IX; HIV, human immunodeficiency virus; SD, standard deviation; SHL, short half-life
  2. Proportions may not sum to 100% due to rounding